Abstract |
The 5-HT2C receptor has been implicated as a critical regulator of appetite. Small molecule activation of the 5-HT2C receptor has been shown to affect food intake and regulate body weight gain in rodent models and more recently in human clinical trials. Therefore, 5-HT2C is a well validated target for anti- obesity therapy. The synthesis and structure-activity relationships of a series of novel tetrahydropyrazinoisoquinolinone 5-HT2C receptor agonists are presented. Several members of this series were identified as potent 5-HT2C receptor agonists with high functional selectivity against the 5-HT2A and 5-HT2B receptors and reduced food intake in an acute rat feeding model upon oral dosing.
|
Authors | Guohua Zhao, Chet Kwon, Sharon N Bisaha, Philip D Stein, Karen A Rossi, Xueying Cao, Thao Ung, Ginger Wu, Chen-Pin Hung, Sarah E Malmstrom, Ge Zhang, Qinling Qu, Jinping Gan, William J Keim, Mary Jane Cullen, Kenneth W Rohrbach, James Devenny, Mary Ann Pelleymounter, Keith J Miller, Jeffrey A Robl |
Journal | Bioorganic & medicinal chemistry letters
(Bioorg Med Chem Lett)
Vol. 23
Issue 13
Pg. 3914-9
(Jul 01 2013)
ISSN: 1464-3405 [Electronic] England |
PMID | 23683593
(Publication Type: Journal Article)
|
Copyright | Copyright © 2013 Elsevier Ltd. All rights reserved. |
Chemical References |
- Isoquinolines
- Pyrazines
- Receptor, Serotonin, 5-HT2C
|
Topics |
- Animals
- Crystallography, X-Ray
- Dose-Response Relationship, Drug
- Eating
(drug effects)
- Humans
- Isoquinolines
(chemical synthesis, chemistry, pharmacology)
- Models, Molecular
- Molecular Structure
- Pyrazines
(chemical synthesis, chemistry, pharmacology)
- Rats
- Receptor, Serotonin, 5-HT2C
(metabolism)
- Structure-Activity Relationship
|